Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Deferasirox Dispersible Tablets

Approval Number

国药准字H20244694

Company中美华世通生物医药科技（武汉）股份有限公司

Registration Date

August 20, 2024

Drug Information

Generic Name

地拉罗司分散片

Dosage Form

片剂

Strength

125mg

Drug Type

化学药品

Registration Date

August 20, 2024

Company Information

Applicant Company

Company Name中美华世通生物医药科技（武汉）股份有限公司

Company Address

武汉东湖开发区高新大道666号武汉国家生物产业基地项目B、C、D区研发楼B3-4栋

Manufacturing Company

Company Name湖北华世通生物医药科技有限公司

Company Address

湖北天门经济开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy